Page last updated: 2024-10-22

albuterol and Alveolitis, Fibrosing

albuterol has been researched along with Alveolitis, Fibrosing in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kramer, EL1
Mushaben, EM1
Pastura, PA1
Acciani, TH1
Deutsch, GH1
Khurana Hershey, GK1
Korfhagen, TR1
Hardie, WD1
Whitsett, JA1
Le Cras, TD1

Other Studies

1 other study available for albuterol and Alveolitis, Fibrosing

ArticleYear
Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.
    American journal of respiratory cell and molecular biology, 2009, Volume: 41, Issue:4

    Topics: Airway Resistance; Albuterol; Animals; Bronchial Hyperreactivity; Cells, Cultured; Disease Models, A

2009